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Abstract
Background: Variability between clinical practice guideline recommendations and actual clinical practice exists in
many areas of health care. A 2004 systematic review examining the effectiveness of guideline implementation
interventions concluded there was a lack of evidence to support decisions about effective interventions to
promote the uptake of guidelines. Further, the review recommended the use of theory in the development of
implementation interventions. A clinical practice guideline for the management of acute low-back pain has been
developed in Australia (2003). Acute low-back pain is a common condition, has a high burden, and there is some
indication of an evidence-practice gap in the allied health setting. This provides an opportunity to develop and
test a theory-based implementation intervention which, if effective, may provide benefits for patients with this
condition.
Aims: This study aims to estimate the effectiveness of a theory-based intervention to increase allied health
practitioners’ (physiotherapists and chiropractors in Victoria, Australia) compliance with a clinical practice guideline
for acute non-specific low back pain (LBP), compared with providing practitioners with a printed copy of the
guideline. Specifically, our primary objectives are to establish if the intervention is effective in reducing the
percentage of acute non-specific LBP patients who are either referred for or receive an x-ray, and improving mean
level of disability for patients three months post-onset of acute LBP.
Methods: The design of the study is a cluster randomised trial. Restricted randomisation was used to randomise
210 practices (clusters) to an intervention or control group. Practitioners in the control group received a printed
copy of the guideline. Practitioners in the intervention group received a theory-based intervention developed to
address prospectively identified barriers to practitioner compliance with the guideline. The intervention primarily
consisted of an educational symposium. Patients aged 18 years or older who visit a participating practitioner for
acute non-specific LBP of less than three months duration over a two-week data collection period, three months
post the intervention symposia, are eligible for inclusion. Sample size calculations are based on recruiting between
15 to 40 patients per practice. Outcome assessors will be blinded to group allocation.
Trial registration: Australian New Zealand Clinical Trials Registry ACTRN12609001022257 (date registered 25
th
November 2009).
Background
Dozens of evidence-based clinical practice guidelines
(CPGs) are published annually with the potential to
improve the quality and safety of health care. However,
failure to implement CPG recommendations has
resulted in patients receiving care that is inappropriate,
unnecessary, or even harmful [1-3]. Effective interven-
tions are needed to address the barriers to change
required for successful implementation of CPGs. * Correspondence: joanne.mckenzie@monash.edu
1School of Public Health and Preventive Medicine, Monash University,
Melbourne, Australia
Full list of author information is available at the end of the article
McKenzie et al. Implementation Science 2010, 5:86
http://www.implementationscience.com/content/5/1/86
Implementation
Science
© 2010 McKenzie et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.The most comprehensive systematic review to date
identified small to moderate effects of most interven-
tions to implement CPGs [4]. Despite some promising
interventions, existing studies provide limited guidance
on the factors that moderate the effects of these inter-
ventions in different settings, professional groups, and
for different targeted behaviours. Consequently, we
know little about how to formulate effective strategies
for implementing CPGs. The use of theory has been
advocated to inform intervention development with the
potential to improve our understanding of why a parti-
cular intervention may be effective [5,6]. Theory can
provide an explicit basis for identifying determinants of
change and intervention techniques to modify these
determinants. This approach is supported by the United
Kingdom (UK) Medical Research Council (MRC) frame-
work for developing and evaluating complex interven-
tions [7]. Our protocol focuses on the last phase of this
framework: assessing effectiveness, cost-effectiveness,
and understanding change processes [8].
Low back pain (LBP) is a common and costly pro-
blem. At any one time, 26 in every 100 Australians have
LBP, and 79% of Australians will experience it at some
time in their lives [9]. The direct and indirect cost of
LBP in 2001 was estimated to total AUD 9,175 million
[10]. In 2003, the Australian National Health and Medi-
cal Research Council (NHMRC) endorsed a CPG for
acute LBP [11] that provided evidence for the diagnosis,
prognosis and treatment of acute non-specific LBP. The
relevant key messages are: that plain x-rays of the lum-
bar spine are not routinely recommended for people
with acute non-specific LBP because they are of limited
diagnostic value and provide no benefits in pain, func-
tion, or quality of life [11]; and advising these patients
to stay active produces a beneficial effect on pain, rate
of recovery, and function when compared to bed rest
and a specific exercise regimen (based on level I evi-
dence) [11]. While the NHMRC CPG was published in
2003, recent systematic reviews of randomised trials still
support these two recommendations [12-14].
The CPG was disseminated in 2004 via: distribution of
an evidence summary booklet to 40,000 practitioners in
Australia, including allied health practitioners; distribu-
tion of consumer information sheets; and publicising the
availability of materials on the NHMRC website. It is
likely, therefore, that most practitioners who manage
people with LBP will be aware of and have access to the
CPG. However, recent research in Australian general
practice indicates that patterns of LBP management (par-
ticularly in relation to the x-ray and advice to stay active
behaviours) by general practitioners (GPs) have remained
unchanged [15]. To our knowledge, the effect that disse-
mination of the CPG has had on Australian allied health
practitioners’ behaviour has not been studied.
There is a need to establish effective methods for facili-
tating the uptake of CPGs in allied health. About
one-third of the care for LBP in Australia is provided by
physiotherapists and chiropractors [16], however
research suggests that care is not always consistent with
the CPG recommendations. International studies demon-
strate that chiropractors often investigate people with
a c u t en o n - s p e c i f i cL B Pu s i n gp l a i nr a d i o g r a p h y[ 1 7 - 2 3 ] .
Physiotherapy management is less likely to include refer-
ral for plain x-ray, however Australian physiotherapists’
self-reported use of x-rays for acute non-specific LBP is
still too frequent [22], and physiotherapists feel uncertain
regarding the value of CPGs [24,25].
A number of randomised trials have investigated the
effectiveness of interventions to increase compliance with
CPG recommendations for the management of LBP by
GPs [26-38]. However, there has been little equivalent
research in allied health settings [39], with only three
cluster randomised trials (CRTs) reported – one in the
Netherlands [40,41], and two in the UK [42,43]. The
Netherlands CRT evaluated the effectiveness of an inter-
vention consisting of two interactive workshops designed
to address barriers to implementation [40,41]. Practi-
tioners in the intervention group followed the CPG more
frequently (odds ratio (OR) 2.05; 95% confidence interval
(CI) 1.15 to 3.65); however, this did not result in better
patient outcomes. A UK CRT assessed the effectiveness
of an evidence-based, local opinion leader-led LBP edu-
cational program compared to receiving in-service train-
ing on knee pathology management and found no
evidence of a difference in the odds of practitioners rat-
ing ‘providing advice to return to normal activities’ in the
top five most important treatments delivered to acute
LBP patients [42]. However, the confidence interval was
wide and did not exclude potentially important effects.
Another UK CRT compared practitioners receiving a
printed information package providing evidence-based
recommendations to no intervention [43]. Practitioners
in the intervention group were more likely to record pro-
viding advice to stay active in response to a single clinical
v i g n e t t e( O R1 . 2 9 ;9 5 %C I1 . 0 3t o1 . 6 1 ) .H o w e v e r ,t h e s e
studies did not investigate mechanisms of action of the
interventions, limiting the extent to which it is possible
to explain their findings using theories of behaviour
change.
We have recently completed a CRT investigating the
effectiveness of a theory-based intervention for imple-
menting the NHMRC CPG in general practice (the
IMPLEMENT trial) [33]. The current trial (the ALIGN
trial) extends this work to allied health. At the writing
of this protocol (March to May 2010), baseline data col-
lection, and the physiotherapy and chiropractic interven-
tions have taken place. Data collection of the patient
participants has just begun.
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The primary objective of the ALIGN trial is to esti-
mate the effectiveness of a theory-based intervention
that aims to increase physiotherapists’ and chiroprac-
tors’ (in Victoria, Australia) compliance with a CPG
for acute LBP, compared with providing practitioners
with a printed copy of the guideline. Specifically, our
primary objectives are to establish if the intervention is
effective in:
(i) Reducing the percentage of acute non-specific
LBP patients who are either referred for an x-ray, or
receive an x-ray (practitioner behaviour);
(ii) Improving the mean level of disability for
patients three months post-onset of an episode
of acute non-specific LBP (patient level health
outcome).
Secondary objectives include estimating the effects of
the intervention for secondary outcomes in the follow-
ing categories: (i) practitioner behaviour (provided
advice to stay active, advised bed rest, referred for ima-
ging excluding x-ray), (ii) predictors of practitioner
behaviour (practitioner intention to behave in a manner
consistent with the CPG’s recommendations, beha-
vioural constructs (e.g., knowledge, beliefs about capabil-
ities)), (iii) patient health outcomes (pain severity,
health-related quality of life (HRQoL)), (iv) patient
health behaviour (x-ray occurred), and a (v) predictor of
patient health behaviour (patients’ fear-avoidance beliefs
(FAB)). In addition, we will assess cost-effectiveness
based on the practitioner and patient-level outcomes
described above, as well as assessment of HRQoL, health
service utilisation, and productivity gains/losses.
Methods
Trial design
The design of the trial will be a cluster randomised trial,
with the clusters being physiotherapy or chiropractic
practices including one or more practitioners. There are
challenges to employing a cluster randomised design
compared to patient randomised trials. These include
increased sample sizes, with associated additional costs
and complexity, and increased risk of selection bias at
the patient level [44,45]. Selection bias has been shown
to occur in cluster trials from selective recruitment of
participants by individuals who have knowledge of the
allocation status [46]. Despite these challenges, randomi-
sation at the practice level has the benefit of reducing
potential contamination occurring from practitioners
concurrently managing intervention and control
patients, as would occur in a patient randomised trial
[47-49], and practitioners within the same practice
receiving different interventions, as would occur if
practitioners were randomised. The latter ‘contamina-
tion’ may be seen as beneficial when randomisation
occurs at the practice level, because this may result in
greater diffusion of the intervention from interactions
between practitioners [50]. Therefore in the ALIGN
trial, randomisation at the practice level minimises the
potential for contamination between intervention and
control groups, while increasing the potential for diffu-
sion of the intervention within intervention practices.
Eligibility and recruitment
Recruitment of physiotherapy and chiropractic practices
Sampling frames of physiotherapy and chiropractic prac-
titioners were created from lists provided by their
respective Victorian Registration Boards. Updated con-
tact details and information on their practices were
obtained from the national telephone directory, an inter-
net version of the Yellow Pages® 2009. Practitioners who
were unlikely to be eligible (e.g., those practising in ter-
tiary hospitals or practices obviously not providing care
for acute LBP patients) were removed from the sample
frame. All remaining practitioners were approached and
invited to participate (2,463 physiotherapists and 1,196
chiropractors). Practitioners were sent an invitation let-
ter, explanatory statement,a n dc o n s e n tf o r m .T h o s e
who did not respond were sent a maximum of four
reminder letters, each three weeks apart. When one
practitioner in a practice agreed to participate, a list of
all practitioners employed at that practice was created,
and invitation letters were sent to the other practitioners
informing them that the practice was included, encoura-
ging them to participate, and allowing them to object to
the practice participating if they wished. If the latter
occurred, we planned to contact the practice manager
for direction on whether the consenting practitioners
within the practice could participate.
To increase the awareness of the trial, notices were
placed in professional newsletters and the trial was pro-
moted at conferences. Strategies to promote participation
in the trial included offering professional development
points (for chiropractors in the intervention group only),
payment for assistance in accessing clinical files of
patients with acute LBP (AUD 5 per patient), and entry
into a draw to win a prize to attend a professionally rele-
vant conference in Australia (up to a maximum of AUD
800). In addition, practitioners were advised that some
randomly selected participants would have the opportu-
nity to discuss LBP management with colleagues and
experts in the field.
We initially intended to recruit 136 practices (68 phy-
siotherapy and 68 chiropractic practices), but received a
better than expected response with 210 practices
wishing to participate. This included 133 physiotherapy
practices with 180 physiotherapists, and 77 chiropractic
McKenzie et al. Implementation Science 2010, 5:86
http://www.implementationscience.com/content/5/1/86
Page 3 of 17practices with 88 chiropractors. Given the uncertainty in
the parameters informing our sample size calculation
(e.g., intra-cluster correlation coefficient (ICC), see ‘Sam-
ple size’ section), we made a decision to include all
practices.
Recruitment of patient participants
Practitioners will recruit patient participants over a two-
week period at least three months post the intervention
symposia. Practices will be provided with study explana-
tory statements to distribute to all patients over this
period. At each consultation over this period, practi-
tioners will complete a de-identified patient encounter
form recording, at a minimum, the date and start time
of the encounter. The practitioner will provide a brief
explanation about the study and will ask each patient
for verbal consent to comple t eac h e c k l i s ta b o u tt h e i r
visit. If the patient consents, the practitioner will record
basic demographic information (date of birth, sex, post
code) and will determine if the patient meets the trial’s
inclusion criteria. Consenting patients with acute non-
specific LBP who also meet other eligibility criteria will
be considered patient participants. For these patients,
the practitioner will complete a checklist of diagnostic
procedures and interventions they have ordered, under-
taken, or recommended. At the conclusion of the
consultation, the practitioner will provide patient parti-
cipants with additional documentation regarding further
participation in the trial if they wish.
Patient participants will be provided with a brief
checklist to complete and a blank envelope. The check-
list asks what diagnostic procedures and interventions
they have received, and also invites them to participate
further in the trial by consenting to additional data col-
lection, either through completion of a survey at three
months post-onset of acute LBP, or allowing their clini-
cal file to be audited by the research team, or both.
Patient participants will be asked by the practitioner to
complete the checklist before leaving the practice, place
it in the provided envelope, seal the envelope, and put it
in the box at reception. Those who are unable to com-
plete the checklist at the time of their consultation will
be given the option of posting the checklist directly to
the research team. Patient participants will be informed
that their care will not be affected by their participation
in the trial, and that the information they provide will
not be available to practitioners at the practice. Patient
participants will remain de-identified, unless they con-
sent to additional data collection (completion of survey
or file audit, or both). To promote participation in addi-
tional data collection, patients will be offered the incen-
tive of being entered into a draw to win a mobile phone.
The patient recruitment process has the potential
to introduce selection bias because patients are recrui-
ted post-randomisation, and this is undertaken by
practitioners who are aware of their own allocation sta-
tus [51]. In cluster trials such as ALIGN, which include
patients with an acute condition, it is generally not pos-
sible to recruit patient participants prior to randomisa-
tion of practices [45]. Potential strategies for minimising
selection bias occurring through patient recruitment in
ALIGN included (i) researchers blinded to group alloca-
tion recruiting in practices, (ii) reception staff recruiting
patients, (iii) researchers blinded to group allocation
searching clinical files without patient consent, (iv)
using de-identified data produced by software for trawl-
ing electronic clinical files, and (v) using administrative
data. It was not possible for us to implement any of
these options. We did not have the resources available
to place recruiters at each of the practices (option (i)).
Some practices did not have reception staff, precluding
the use of option (ii). Australia’s state and common-
wealth privacy legislation does not allow researchers to
access clinical files without patient consent (option (iii))
[52]. Most physiotherapy and chiropractic practices do
not use electronic clinical files, precluding the use of
option (iv). Finally, unlike in the general practice setting
where administrative data on x-ray referral is available
(MediCare Australia), this data is not available for phy-
siotherapists and chiropractors. Given these limitations,
we plan to report data to assess potential selection bias.
Details are available in sections ‘Analysis subsets’ and
‘Descriptive analyses at baseline.’
Inclusion criteria
Physiotherapy and chiropractic practices were included
if the following criteria were met:
1. At least one practitioner within the practice pro-
vided written informed consent.
2 .T h ep r a c t i c ew a sl o c a t e di nt h es t a t eo fV i c t o r i a ,
Australia.
Physiotherapists and chiropractors were included if
they provided written informed consent and practised
within one of the participating practices.
Patient participants will be included if the following
criteria, determined by the practitioner, are met:
1. They attend a consenting practitioner for acute
non-specific LBP (of duration less than three months).
2. Provide consent.
3. Are 18 years of age or older.
4. Are able to understand and read English.
Exclusion criteria
Physiotherapy and chiropractic practices were excluded
if the practice manager objected to any practitioners
within the practice participating in the trial.
Physiotherapists and chiropractors were excluded if
any of the following criteria were met:
1. They were investigators of the trial.
2. They were members of the ALIGN advisory
committee.
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development of the intervention.
4. They worked at more than one of the included
practices in the trial.
Patients attending the enrolled practices will not be
eligible for inclusion if any of the following criteria are
met. These criteria reflect the clinical scope of the acute
LBP NHMRC CPG [11].
1. Radicular leg pain is present; this is defined as leg
pain described as shooting, lancinating, or electric in
quality, extends below the knee, has a dermatomal dis-
tribution with or without paraesthesia.
2. They have had previous spinal surgery.
3. ‘Red flags’ are present alerting the possibility of ser-
ious conditions such as malignancy, infection, or
fracture.
4. They are pregnant.
Randomisation and allocation concealment
Practices meeting the inclusion criteria were randomly
allocated at the same time to receive either the interven-
tion or control. Restricted randomisation was used to
reduce the probability of baseline imbalance in potential
confounding variables, and to provide greater statistical
power [50]. Four strata were defined by professional
group (physiotherapists and chiropractors) and the loca-
tion of the practice (rural or metropolitan; defined from
the Rural, Remote, and Metropolitan Areas classification
system [53]). Within stratum, practices were allocated to
the intervention and control groups with equal probabil-
ity (1:1 randomisation ratio). This was achieved by gen-
erating a computer random number (in the statistical
software package Stata [54]) for each practice, sorting
on the random number within each stratum, and allo-
cating every alternate practice to the intervention group.
Professional group was considered an important strati-
fication variable, because management of patients with
acute non-specific LBP may vary because of professional
training and philosophy. A survey of Australian primary
care physicians, including physiotherapists and chiro-
practors, suggested a difference in self-reported x-ray
use for acute non-specific LBP between the professional
groups [22]. In addition, in 2009 we undertook a survey
investigating the attitudes, beliefs, and intentions of phy-
siotherapists and chiropractors in Australia, regarding
their management of patients with acute LBP (response
rate = 33%, sample size = 469). Differences in intention
t or e f e rp a t i e n t sf o rx - r a ya n dp r o v i d ea d v i c et os t a y
active were found between the professional groups. Spe-
cifically, of the next 10 patients presenting with acute
LBP, chiropractors intended to refer 3.7 (95% CI 3.2 to
4.3) more patients for an x-ray compared to phy-
siotherapists, and provide advice to stay active to 0.6
(95% CI 0.4 to 0.9) fewer patients (Unpublished data:
O’Connor D, Monash University, Australia).
We made a decision to include location of the practice
as a stratification variable because the rates of x-ray
referral may vary with geographical proximity to ima-
ging centres, and because of geographic variation in
socioeconomic barriers to health service utilisation,
including diagnostic imaging [55].
Finally, consideration was given to stratifying by clus-
ter size. Cluster size is quite commonly used as a strati-
fication variable in community intervention trials [50]
because the size of a cluster is often a proxy for other
variables, which may be predictive of outcome, but are
more difficult to measure (e.g., educational environment
within a practice). In the ALIGN trial, we did not stra-
tify by size of the practice because we were not able to
obtain accurate information on this variable.
A statistician who was independent of the trial team
undertook the randomisation. He was provided with a
file containing practice codes and stratification variables.
The file contained no identifying information about the
practices.
Blinding
It was not possible to blind investigators involved in the
delivery of the intervention to group allocation. In addi-
tion, due to the nature of the intervention, it was not
possible to blind the practitioners to group allocation.
However, practitioners only received minimal informa-
tion about the intervention content in the recruitment
material. They were informed that they may have to
access materials about management of LBP either
through the Internet, or they may be invited to attend
an interactive workshop. Patient participants will be
informed through recruitment materials that their prac-
titioner is participating in a study assessing practitioners’
management of patients presenting with acute LBP; they
w i l ln o tb ei n f o r m e do ft h es t u d yd e s i g n ,a n dt h e r e f o r e
of their practitioners’ group allocation. However,
because the practitioner is not blinded, it is possible
that they might reveal their allocation to participating
patients. Outcome assessors extracting data from clinical
files of patients, and research assistants entering practi-
tioner and patient completed checklists and question-
naires, will be blinded to group allocation. The trial
statistician will not be blinded to group allocation.
Interventions
Control group
Participants in control group practices received a
printed copy of the summary version of the guideline
and a written reminder of how to access it [11]. For
some practitioners, this provides an additional exposure
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NHMRC in 2004.
Intervention group
Intervention group practitioners received a theory-based
implementation intervention developed to address the
hypothesised determinants of CPG implementation
identified in phase one of this project. In phase one,
semi-structured interviews, underpinned by a theoretical
domains framework [56], were conducted with phy-
siotherapists and chiropractors in Victoria, Australia.
Thematic analysis was used to map the identified bar-
riers and facilitators of the target behaviours to the the-
oretical domains framework. The most salient domains
identified formed the basis of a survey, which was dis-
tributed to a random sample of practising physiothera-
pists and chiropractors in Victoria, South Australia, and
Western Australia. The survey quantified the association
between constructs from these domains and intention to
practice in a manner consistent with the guideline
recommendations. Both the findings of interviews and
survey informed the design of the intervention, and will
be published elsewhere.
The intervention consisted of: a full-day symposium-
style event involving a combination of didactic lectures
delivered by peer opinion leaders (identified in consulta-
tion with representatives from the physiotherapy and
chiropractic associations), small group discussion led by
trained clinical facilitators, and practical sessions; sup-
porting written material; and a follow-up phone call.
Separate symposia were held for physiotherapists and
chiropractors. All practitioners in the intervention
group, including those who were not able to attend the
symposium, received a DVD including videos of the
didactic sessions and printed resources about LBP man-
agement. A clinical member of the project team
attempted to follow-up all practitioners with a telephone
call to discuss difficulties encountered in implementing
behaviours and strategies to overcome these. More
detail on the intervention, including the development
process, will be reported in a separate publication. Sym-
posia details are available in Additional File 1 - ‘ALIGN
intervention content.’
Finally, while not formally a component of the inter-
vention or control group, the practitioner data collection
procedure involves completion of patient checklists
about LBP management and may act as a prompt to
change practitioner behaviour. The checklist includes a
broad range of diagnostic procedures and interventions
potentially used for patients with acute non-specific
LBP, irrespective of supporting evidence.
Timing of recruitment, intervention delivery, and follow-up
T h ep h y s i o t h e r a p i s ta n dc h i r o p r a c t i cs y m p o s i at o o k
place on 20 and 27 February 2010, respectively. Practi-
tioners in the intervention group were mailed a DVD of
material from the symposium for their professional
group on 29 March 2010. Practitioners in the interven-
tion group received a follow-up phone call two to four
weeks after either attending the symposium or being
sent the DVD. Materials were sent to the control group
on 10 March 2010.
Patient participant recruitment will take place over a
five-week period, beginning at least three months post-
symposium delivery (31 May 2010). Each practice will
recruit patients for a period of two weeks (a longer per-
iod was judged to place too great a burden on practi-
tioners). Practices will be randomly allocated to recruit
patients in either the first (31 May to 11 June 2010) or
second (21 June to 2 July 2010) data collection period.
Practitioners who are not able to collect data in either
of these periods (e.g., on holiday), will be invited to
select an alternative fortnight of data collection between
July and September 2010.
Figure 1 details the timing of recruitment, intervention
delivery, and data collection periods for practitioner and
patient participants.
Intervention fidelity
We will evaluate intervention fidelity, which is the
extent to which the intervention, as delivered, was
adhered to as planned [57]. The proportion of practi-
tioners in the intervention group who attended the
symposium, received the follow-up call, and viewed the
DVD has been documented. The symposia were audio-
and video-recorded and will be transcribed verbatim.
Observed adherence will be assessed by content analy-
sis of the symposium transcripts to evaluate which
intervention sections were covered, and which beha-
viour change techniques were delivered. An indepen-
dent assessor attended each symposium and completed
a checklist to indicate whether or not planned inter-
vention components and behaviour change techniques
were used. We will report the proportion of practi-
tioners who received each different component of the
intervention and the data from the checklist completed
by the independent assessor in the main trial publica-
tion; the remaining components of this evaluation will
be reported in a separate publication.
Study outcomes
Primary outcomes
The primary outcome at the practitioner level is
whether the practitioner orders, undertakes, or recom-
mends a lumbar x-ray for the acute non-specific LBP
patient over the two-week data collection period (occur-
ring three months post-symposium). The primary out-
come at the patient level is LBP specific disability three
months post-onset of their acute LBP episode (Table 1).
The rationale for selecting these outcomes as primary
outcomes is fully described in McKenzie et al.[ 3 3 ] .
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mendations from the CPG: diagnostic plain x-rays of the
lumbar spine are rarely necessary in the management of
acute LBP, and patients should be advised to remain
active. The primary outcome at the practitioner level
measures the effectiveness of the intervention in chan-
ging the practitioners’ behaviour for the first recommen-
dation, x-ray referral. The primary outcome at the
patient level measures the effectiveness of the interven-
tion in changing the practitioners’ behaviour for the sec-
ond recommendation, providing advice to stay active,
and assessing whether this change results in improve-
ments for the patients in terms of short-term disability.
Secondary outcomes
Secondary outcomes include measures of practitioner
behaviour (provided advice to stay active, advised bed
rest, referred for imaging excluding x-ray), predictors of
practitioner behaviour (practitioner intention to behave
in a manner consistent with the CPG’s recommenda-
tions, behavioural constructs), patient health outcomes
(pain severity, HRQoL), a predictor of patient health
behaviour (FAB), and a patient health behaviour (x-ray-
occurred). The outcomes, data collection methods, and
assessment periods are included in Tables 1 and 2. Justi-
fication for the inclusion of these outcomes follows.
Practitioner behaviour The outcome ‘imaging referral
excluding x-ray’ has been included to estimate the effect
of the intervention on practitioners’ referral for other
types of imaging. Including this outcome stems from a
concern that while practitioners may reduce their use of
x-rays, they may concurrently increase their use of other
forms of imaging. Other forms of imaging are rarely
recommended for acute LBP [11]. The outcomes ‘advice
to stay active’ and ‘advised bed rest’ have been included
as additional measures to assess the effectiveness of the
intervention in changing practitioners’ behaviour, with
advice to stay active recommended, and advising bed
rest not recommended. These outcomes are predicted
to mediate the relationship between the intervention
and patient LBP specific disability.
Predictors of practitioner behaviour We have included
measures of behavioural intention and other behavioural
constructs (such as knowledge and beliefs about capabil-
ities) as predictors of behaviour. Several outcomes mea-
suring practitioners’ intentions toward behaving in a
manner consistent with the CPG’s two recommendations
Figure 1 Timing of recruitment, intervention delivery, follow-up of practitioner, and patient participants.
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dictive of behaviour [58]. Intention is considered sepa-
rately from the other behavioural constructs because it is
thought to mediate the relationship between these
constructs and actual behaviour. Details of the other
behavioural constructs are reported in Additional File 2 -
‘ALIGN outcome definitions’ and Additional File 3 -
‘ALIGN data collection instruments.’
Patient health outcomes We have included pain sever-
ity as an additional measure of the effectiveness of the
intervention on patient level health outcomes because
pain severity is a recommended core outcome measure
in LBP research [59]. In addition, it is useful to examine
if the small benefits on pain observed in patient rando-
mised trials, which underpinned the guidelines, are
observed in a pragmatic setting with a less intensive
patient level intervention.
We have included a preference-based measure of
HRQoL in the set of patient-level outcomes to facilitate
estimation of intervention effects in terms of quality
adjusted life-years (QALYs). QALYs are commonly used
in healthcare priority setting to compare interventions
over multiple dimensions of HRQoL (in this case pain,
pain-related disability, and physical function inter alia).
Measurement of QALYs will permit the results of cost-
effectiveness analyses to be expressed in terms of incre-
mental cost per QALY.
Predictor of patient health behaviour Fear-avoidance
beliefs, measured at the patient level, will be included
as a potential predictor of patient health behaviour.
Table 1 Outcome measures
Outcome
(outcome category)
Data collection method Outcome assessment
period
Source Level data
collected at
Inference intended at the practitioner level
X-ray referral
(practitioner behaviour)
1
Checklist completed by
practitioner
3 to 4 months post-
symposium
Practitioner Patient
Advice to stay active
(practitioner behaviour)
Checklist completed by
practitioner
3 to 4 months post-
symposium
Practitioner Patient
Imaging referral excluding x-ray
(practitioner behaviour)
Checklist completed by
practitioner
3 to 4 months post-
symposium
Practitioner Patient
Advised bed rest
(practitioner behaviour)
Checklist completed by
practitioner
3 to 4 months post-
symposium
Practitioner Patient
X-ray referral (file audit)
(practitioner behaviour)
Clinical file audit 0 to 7 months post-
symposium
Practitioner case
notes
Patient
Imaging referral excluding x-ray (file audit)
(practitioner behaviour)
Clinical file audit 0 to 7 months post-
symposium
Practitioner case
notes
Patient
Intention to adhere to CPG recommendations: Questionnaire Baseline, 4 months post-
symposium
Practitioner Practitioner
X-ray referral
Imaging referral excluding x-ray
Advice to stay active
Bed rest advice
(predictor practitioner behaviour)
Behavioural constructs
2 (e.g., knowledge, beliefs
about capabilities)
(predictor practitioner behaviour)
Questionnaire Baseline, 4 months post-
symposium
Practitioner Practitioner
Inference intended at the patient level
LBP specific disability
1
(health outcome)
Questionnaire 3 months post-onset acute
LBP episode
Patient Patient
Pain severity
(health outcome)
Questionnaire 3 months post-onset acute
LBP episode
Patient Patient
X-ray occurred
(health behaviour)
Questionnaire 3 months post-onset acute
LBP episode
Patient Patient
Fear-avoidance beliefs
(predictor health behaviour)
Questionnaire 3 months post-onset acute
LBP episode
Patient Patient
Health-related Quality of Life
(health outcome)
Questionnaire 3 months post-onset acute
LBP episode
Patient Patient
Health Service Utilisation and Productivity
Gains/Losses
Questionnaire 3 months post-onset acute
LBP episode
Patient Patient
Table adapted from McKenzie et al. [33]. See Additional File 2 - ‘ALIGN outcome definitions’ for details of outcome definitions.
1Primary outcome.
2Table 2 provides details of the behavioural construct domains.
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were predictive of disability up to three months after
the index consultation, identified a range of psychosocial
factors, including depression, job physical demands, and
FABs [60]. Fear-avoidance beliefs were more frequently
shown to be associated with acute LBP compared with
other psychosocial factors, and has been included for
this reason.
Patient health behaviour Patients will be asked if they
received an x-ray. When patients do not receive either a
referral for an x-ray or an x-ray from their practitioner,
they may choose to see another practitioner who may
provide an x-ray referral. While evidence of effectiveness
of the intervention in changing x-ray referral rates by
practitioners may be observed, it is of interest to exam-
ine if this ultimately changes the proportion of patients
who receive an x-ray.
Outcome measurement
Practitioner behaviour will be measured through practi-
tioner-completed checklists of patient consultations and
through clinical file audit. Practitioners will complete a
checklist for each patient consultation over the two-week
data collection period, indicating diagnostic procedures
and interventions ordered, undertaken, or recommended.
Outcomes measured through the checklists represent
the practitioners’ self-reported behaviour approximately
three to four months post-symposium delivery. Clinical
file audit will be undertaken for consenting patients.
Outcomes measured through clinical file audit will repre-
sent practitioners’ behaviour over the period zero to
approximately seven months post-symposium delivery.
The practitioner checklist and details of the data to be
extracted from clinical file audit are available in Addi-
tional File 3.
Predictors of practitioner behaviour will be measured
through a questionnaire, administered as a paper-based
questionnaire or through the internet, at baseline and
approximately four months following symposium
delivery.
Patient health outcomes, patient health behaviour, and
predictor of patient health behaviour, will be measured
through a questionnaire, administered as a paper-based
questionnaire or through the internet, at three months
post-onset of their acute LBP episode. The patient ques-
tionnaire is available in Additional File 3.
Details of the outcome definitions are available in
Additional File 2.
Data quality assurance
Completed practitioner and patient questionnaires will
be checked for errors and missing data as they are
returned, and participants will be followed up to clarify
anomalies. Double data entry will be used for paper-
based questionnaires, and practitioner- and patient-
completed checklists. When inconsistencies are found,
these will be corrected by referring back to the paper-
based version. Practitioner-completed checklists will be
checked, as they are returned, to determine if there are
items or sections that have consistent errors or missing
data. When this occurs, practitioners will be followed up
to discuss any misunderstandings in completing the
Table 2 Behavioural construct domains
Domain measured for
behaviour
Domains Explanation X-ray
referral
1
Advice to
stay
active
2
Behavioural intention
Intention The extent to which the practitioner intends to perform the behaviour. ✓✓
Other behavioural domains
Beliefs about capabilities The extent to which the practitioner feels confident in/control over performing the
behaviour.
✓✓
Beliefs about consequences The extent to which the practitioner is in favour of performing the behaviour and has
positive behavioural beliefs.
✓✓
3
Knowledge Whether the practitioner has knowledge of the behaviour. ✓✓
Professional role and identity The extent to which the practitioner feels it is their professional responsibility to perform
the behaviour.
✓✓
Social influences The extent to which the practitioner feels social pressure to engage in the behaviour. ✓✓
Environmental context and
resources
The extent to which the practitioner feels the environmental context supports
performance of the behaviour.
✓✓
Memory The extent to which the practitioner remembers to perform the behaviour. ✗✓
1Managing patients without referral for plain x-ray.
2Advising patients to stay active.
3Includes measurement of practitioners’ fear-avoidance beliefs about physical activity and pain.
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follow-up data collection will be contacted if there is
missing data on their patient completed checklist. Prac-
titioners of these patient participants will be contacted if
there is missing data on the practitioner-completed
checklist. Processes will be put in place to monitor the
number of practitioner- and patient-completed check-
lists received each day over the data collection period.
A continuous sampling plan will be used to check a
sample of data extracted from patient clinical files
[61,62].
Sample size
The primary practitioner outcome is x-ray referral. In our
original sample size calculation for this outcome, we
estimated that we would require 136 practices (68 phy-
siotherapy and 68 chiropractic practices), each complet-
ing checklists for an average of 20 patient participants
(providing a total of 2,720 patient participants), to pro-
vide 80% power to detect a difference of 10% in x-ray
referral between intervention groups. This assumed a
39% x-ray referral rate in the control group, a 5% signifi-
cance level, and an ICC of 0.10, and allowed for 20%
attrition in practices. Empirical research has suggested
ICCs of the order of 0.10 for process variables, such as
x-ray referral, in primary care [63]. Data on x-ray referral
rates were not available for the Australian context, so the
x-ray referral rate of 39% was estimated from interna-
tional research and assumptions regarding the process of
x-ray referral in Australia. More specifically, for chiro-
practors, several international studies have estimated that
referral for x-ray for acute LBP ranges from 62% to 72%
[17,20,23]. For physiotherapists, we assumed that x-ray
referral rates would be similar to those found in Austra-
lian general practice, which has been estimated at 28%
[64], because many physiotherapists treat patients with
LBP on referral from, and in conjunction with, GPs.
Because we intended to recruit an equal number of
patient participants from physiotherapy and chiropractic
practices, we estimated the pooled x-ray referral rate to
be 47%. Interventions comparing standard CPG dissemi-
nation with no intervention control groups have shown
improvements in care of approximately 8% [4]. We there-
fore anticipated a decrease in the percentage of x-ray
referral in the control group of this magnitude, providing
an estimated referral rate of 39%.
As previously mentioned, we received a better than
expected response from practices wishing to participate
(133 physiotherapy and 77 chiropractic practices), and
made a decision to include all practices because of
uncertainties in the sample size calculation, including
our estimate of ICC, the average number of patient par-
ticipants for whom checklists are completed per practice
(cluster size), variation in the cluster size, and the
estimated x-ray referral rates. Assuming 168 practices
complete the data collection (allowing for 20% attrition),
we have investigated the likely width of the 95% CI for
the risk difference and the log odds ratio for the primary
practitioner outcome x-ray referral, assuming a range of
values of the sample size parameters (Additional File 4 -
‘ALIGN sample size calculations’). From this investiga-
tion, the width of the 95% CI for the observed difference
in x-ray referral rates between groups is likely to be in
the range of ±5% to ±7%. On the log odds scale, this is
equivalent to a range of ±0.26 to ±0.41.
Effectiveness analyses
Analysis subsets
The principle of intention-to-treat (ITT) is generally the
recommended analysis approach for randomised trials
because it maintains the comparability of the interven-
tion groups, in known and unknown prognostic factors,
brought about through randomisation, thus providing
an unbiased estimate of intervention effect. In addition,
non-compliance by practitioners and patients is allowed
for, therefore providing an estimate of intervention
effect that is more reflective of actual clinical practice
[65,66]. For this reason, ITT analysis has been suggested
for pragmatic trials [67].
In patient randomised trials, requirements of an ideal
ITT analysis include compliance with the randomised
intervention, no missing responses, and follow-up on all
participants [65]. In a CRT, definition and application of
a nI T Ta n a l y s i si sm o r ec h a l l e n g i n g[ 6 8 ]b e c a u s eo f
complexities with the hierarchical structure of the
design and recruitment of participants potentially occur-
ring post-randomisation of the clusters. More specifi-
cally, in a CRT such as ours, practices, practitioners,
and patients may withdraw, or be lost to follow-up. In
addition, during the recruitment phase of patient partici-
pants, practitioners may not actively recruit patients,
potentially leading to empty clusters (this may be differ-
ential by group); they may recruit a differential number
of participants depending on allocation status; or they
may selectively recruit patients (leading to patients with
different characteristics between groups) [68]. Statistical
methods for handling missing data and dealing with
selection bias in CRTs are limited [69], and for some
forms of missing data (empty clusters), there is currently
no statistical solution [68].
We therefore plan to present a modified ITT analysis
as our primary analysis, where we will analyse clusters
and participants (practitioners and patients) as they have
been randomised, regardless of the intervention they
have received, but will not impute missing data. As part
of the secondary analyses, we plan to identify potential
predictors of missing data through modelling, and
include these predictors in the primary analysis model.
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sons for practice, practitioner, and patient withdrawal.
To investigate potential selective recruitment, we will
compare the practice list sizes [45], numbers of
recruited participants, and their characteristics, between
groups (examples of this include [70,71]).
Descriptive analyses at baseline
Descriptive statistics of demographic and potential con-
founding variables will be presented at baseline for the
purposes of investigating the comparability of the inter-
vention groups, and to provide descriptive information
about the study sample. Potential confounding variables
will include those presented in Figure 2, practitioners’
self report of the average number of patients they treat
per week, and the average number of acute LBP patients
they treat per week (collected in the practitioner base-
line questionnaire). In addition, we will compare
between groups measures of the patients’ pain (assessed
by both the practitioner and patient) and general health
(assessed by the practitioner) collected at the first visit
of incident cases of acute LBP over the data collection
period.
Primary analyses
We will estimate the effectiveness of the intervention
on primary and secondary outcomes with marginal
modelling using generalised estimating equations
(GEEs). These models will appropriately account for
correlation of responses within practice. We plan to fit
an exchangeable correlation structure, where responses
from the same practice are assumed to be equally corre-
lated [50,72]. Additionally, we intend to use robust var-
iance estimation that will provide valid standard errors
even if the within-cluster correlation structure has been
incorrectly specified [73,74]. For binary outcomes, a
logit link function will be used. In the event that the
ICC of an outcome for a particular analysis is negative,
we will fit a generalised linear model with no adjust-
ment for clustering (e.g., ordinary linear regression),
making the assumption that in the context of cluster-
based evaluations, negative ICCs are more likely to
occur through sampling error than because of a true
negative ICC [50].
Our primary analyses of outcomes will include adjust-
ment for stratification variables (professional group and
location of the practice) and pre-specified potential con-
founding variables (Figure 2). The potential confounders
have been selected through discussion amongst the
investigators and from published research (see Figure 2
notes). All pre-specified confounders will be included in
the models even when no baseline imbalance exists. We
Figure 2 Potential confounding variables adjusted for in the primary analyses.
1Practitioner checklist;
2Exposure period is the number of
data collection days post-patient entry into the trial.
3Clinical file audit;
4Practitioner questionnaire;
5Stratification variable;
6Imaging referral
excluding x-ray;
7 Adjusted for the baseline of the relevant behavioural construct (e.g., knowledge (Table 2)) for the specified behaviour
(managing patients without referral for plain x-ray or advising patients to stay active);
8Practitioners answer yes to the question ‘Do you primarily
treat Work Cover (compensable) patients at your main practice?’;
9Patient questionnaire;
10Managing patients without referral for plain x-ray;
11Advising patients to stay active; *[100];
†[100,101];
±[102];
‡[103];
·[104];
II [76];
¶[105]; °[106].
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strategies that are based on collected data, (e.g., selecting
confounders using preliminary statistical tests) result in
models with poor statistical properties, such as incorrect
type I error rates [75-78]. In the circumstance that there
is limited data or events (e.g., advised bed rest), or both,
to adjust for all confounders, we will report estimates of
intervention effect from models including only the strati-
fication variables, and baseline of the outcome variables
where appropriate (FAB, intention, and behavioural
constructs).
Estimates of intervention effect from these models
with binary outcomes will yield odds ratios. In addition
to the odds ratios, we plan to also provide estimates of
risk difference to aid interpretability and provide greater
information to fully assess the implications of the inter-
vention effects [79]. Estimates of risk difference will be
estimated from GEEs, with robust variance estimation,
using an identity link function [80]. For each outcome,
the estimate of intervention effect and its 95% CI will be
provided. For the primary outcomes, we plan to provide
estimates of ICCs and their 95% CIs.
Regression diagnostics will be used to assess the influ-
ence of outliers on estimates of intervention effect and
for analysing residuals. No adjustment will be made for
multiple testing. All tests will be two-sided and carried
out at the 5% level of significance.
Secondary analyses
We will conduct a subgroup analysis to examine
whether the effect of the intervention on x-ray referral
is modified by professional group (physiotherapist versus
chiropractor). We hypothesise that the effect of the
intervention may differ by professional group because x-
rays are seen as more integral to the treatment of
patients for chiropractors compared with physiothera-
pists [22]. We will examine this by fitting a model that
includes an interaction term between intervention group
and professional group. The estimated ratio of odds
ratios and its 95% CI will be presented from this model.
GEEs will yield unbiased estimates of intervention
effect only when data are missing completely at random,
or when known covariates that are associated with the
missing data mechanism are included in the model
(missing at random) [69]. As part of the secondary ana-
lyses, we plan to identify potential predictors of missing
data through modelling (e.g., [81]), and include these
predictors in the primary analysis model. We will inves-
tigate methods to impute missing outcome data col-
lected at baseline (e.g., baseline behavioural constructs,
FAB) [82]. Finally, we will investigate methods to adjust
for potential differential recruitment [68].
A disadvantage of using GEEs is that only one level of
clustering can be modelled. For data collected at the
patient level, there are three levels of data: practices,
practitioners, and patients. It is possible to allow for
clustering at the practice level or the practitioner level.
While we have chosen to adjust for clustering at the
practice level, because this is the unit of randomisation,
there may be an argument for adjusting at the practi-
tioner level if the variation at this level is larger; this
could be predicted to arise because the practitioner has
a more direct influence on patient outcomes (such as
x-ray referral). We will therefore undertake sensitivity
analyses investigating the impact of allowing for cluster-
ing at the level of the practitioner.
We plan to undertake explanatory analyses to inves-
tigate if intervention effects are mediated by our
hypothesised predictors of practitioner behaviour
[83-85]. Detailed description of our theoretical model
and results of these explanatory analyses will form
separate publications.
Finally, we plan to undertake analyses comparing the
outcomes (e.g., ‘x-ray referral,’‘ imaging referral excluding
x-ray’) measured via different methods of data collection
(practitioner completed checklists, patient completed
checklists, file audit). In addition, we will undertake sta-
tistical analyses comparing proxy (e.g., clinical decisions
in response to vignettes) and direct methods of measur-
ing clinical behaviour [86]. These analyses will be under-
taken to add to our knowledge about the design of future
trials, but will not be considered part of the trial effective-
ness analyses, and will inform a separate publication.
Economic evaluation
Active implementation entails an additional cost that
may or may not be offset by health gains and/or reduc-
tions in health service utilisation. Evidence is limited
regarding this trade-off between incremental costs (sav-
ings) and effects for active implementation versus simple
dissemination of practice guidelines for management of
LBP. Hoeijenbos et al. [87] conducted a cost-utility ana-
lysis comparing standard dissemination versus active
implementation of the Royal Dutch Physiotherapy Asso-
ciation (RDPA) guideline for non-specific LBP based on
data from the Bekkering CRT [40,41]. While lower per
patient healthcare utilisation in the active implementa-
tion group (mean = EUR 125, SD = EUR 91 versus
m e a n=E U R1 4 5 ,S D=E U R9 5 ,p=0 . 0 2 6 )o f f s e tt h e
relatively modest incremental treatment cost of active
implementation (EUR 366 per physiotherapist), the
observed differences in healthcare utilisation (and health
outcomes) could not be attributed to an intervention
effect due to failure to control for pre-existing between-
group differences in patient characteristics. Hoeijenbos
et al. [87] therefore concluded that ‘it is very likely that
the extended implementation strategy incurs extra costs
without producing health gains, hence it is very likely to
be not cost-effective.’
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et al. [40,41] and the RDPA guideline differ from the
ALIGN intervention and the NHMRC guideline. Impor-
tantly, the RDPA guideline contains no specific recom-
mendation that would limit referral for imaging [88],
and the implementation strategy employed by Bekkering
et al. [40,41] made no attempt to target referral beha-
viour for imaging. Another recently completed study
[33,89] will shortly report on the cost-effectiveness of
active implementation versus standard dissemination of
the NHMRC guideline, but its findings will relate to
general practice rather than to the allied health setting.
Findings from the economic evaluation described here
will therefore complement rather than replicate previous
findings.
Economic evaluation alongside the ALIGN CRT will
be conducted with the aim of quantifying additional
costs (savings) and health gains arising from the ALIGN
intervention as compared to access to the guideline via
existing practice. Secondary aims will be to determine
whether the incremental treatment costs of the ALIGN
intervention are offset by reductions in health service
expenditure (i.e., whether implementing the guideline is
cost-saving as compared with existing practice), and to
determine whether the ALIGN intervention dominates
existing practice (i.e., less costly but no less effective).
The time horizon for inclusion of relevant costs and
consequences for the trial-based evaluation described
here coincides with the final scheduled follow-up of
patient participants (three months post-onset of their
acute LBP episode).
The proposed economic evaluation will take a societal
perspective in identifying, measuring, and valuing costs
and consequences, but some cost categories likely to
produce clinically and economically insignificant varia-
tion in incremental cost will be excluded to simplify our
analysis [90]. Likewise, we exclude some dimensions of
health and HRQoL not captured by the patient-level
outcomes and some (but not all) non-health outcomes
(e.g., social status) on the grounds that their inclusion
would be unlikely to be alter policy recommendations.
Research and evaluation costs will be excluded except
where they might plausibly contribute to a clinically sig-
nificant treatment effect. Costs common and invariant
to both intervention and control groups (e.g., costs asso-
ciated with development and standard dissemination of
the guideline) will not be explicitly calculated for the
incremental analysis described here.
Identification, measurement, and valuation of health
outcomes
In line with the main analysis, the primary outcome for
the economic analysis will be x-ray referral to three
months post-onset of patients’ acute LBP episode based
on the practitioner checklist. For the economic analysis,
we will conduct a secondary analysis under the assump-
tion that referral implies occurrence such that patients
will be coded as ‘x-ray received’ if data from any one of
the practitioner completed checklist, clinical file audit,
or patient questionnaire indicate x-ray referral or occur-
rence. Patients will be coded as ‘x-ray avoided’ if x-ray
referral or occurrence is nowhere indicated in data from
the practitioner completed checklist, clinical file audit,
and patient questionnaire. For the purposes of the eco-
nomic analysis, x-ray referral and x-ray avoided are
intermediate measures of mortality and morbidity effects
that occur beyond trial-end arising due to reduced expo-
sure to ionising radiation [91]. Intervention effects with
respect to x-ray referral and x-ray avoided to three
months post-onset will be estimated using methods spe-
cified for the main analysis, controlling for the set of
potential confounders specified above.
Additional secondary outcomes for the economic ana-
lysis are: any imaging referral (including lumbosacral
plain x-ray, full spine plain x-ray, lumbar CT scan, lum-
bar MRI, or bone scan) and any imaging avoided to
three months post-onset, LBP-specific disability at three
months post-onset, and HRQoL at three months post-
onset. The rationale for measuring referral/avoidance of
any imaging in the economic analysis is as described
above for the outcome ‘imaging referral excluding x-ray.’
Intervention effects with respect to any imaging referral/
avoidance to three months post-onset will be estimated
using methods specified for the main analysis, control-
ling for the set of potential confounders specified above.
LBP-specific disability and HRQoL are included to pro-
vide measures of differential health outcomes arising
within the trial period due to inter alia any between-
group difference in providing advice to stay active. Inter-
vention effects with respect to LBP-specific disability
will be taken from the main analysis of Roland-Morris
Disability Questionnaire (RDQ) at three months post-
onset of their acute LBP episode, controlling for the set
of potential confounders specified above.
Preference-based HRQoL weights derived from the
patient-level AQoL-4D (Assessment of Quality of Life)
responses must be combined with a period of time to
permit estimation of intervention effects in QALY terms
(and incremental cost-effectiveness in cost per QALY
terms). Note, however, that follow up of LBP specific
disability and HRQoL for the ALIGN study is scheduled
for a single time point at three months post-onset. Due
to feasibility/resource constraints and to minimise
patient attrition at the primary endpoint, we decided
not to schedule repeated observations on patient level
outcome measures in the present trial. Findings from
two studies that informed development of the guideline
[92,93] suggest that any intervention effect with respect
to pain is likely to arise in the intermediate term (3 to
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Based on this limited information as to the time-path of
any intervention effect, patients are assumed to transi-
tion from their baseline health state to their observed
health state (as measured by HRQoL at three months
post-onset) at three weeks post-onset, remain stable in
their observed health state (as measured by HRQoL at
three months post-onset) during the nine weeks from
three to twelve weeks post-onset, before transitioning to
full or normal health by trial-end. Intervention effects
with respect to total QALYs are therefore estimated as
the difference between curves for treatment and control
groups over the nine weeks from three to twelve weeks
post-onset of their acute LBP episode using methods
specified for the main analysis of patient level clinical
outcome measures and controlling for the set of poten-
tial confounders specified above. No attempt has been
made to extrapolate from any between-group difference
at trial-end based, for example, on secondary data as to
the relative stability of pain, disability, and return to
work between three and twelve months post-onset [94].
Any between-group differences in transition to chronic
lower back pain are therefore excluded from our esti-
mates of incremental effectiveness.
Identification, measurement, and valuation of resource use
Incremental costs will reflect resource use associated with
development of the implementation intervention, delivery
of the implementation strategy, and any changes in clinical
practice and subsequent health effects. Methods for the
ALIGN cost-analysis will be as described by Mortimer et
al. [89] for the IMPLEMENT trial (planned analyses) but
paid and unpaid costs of homecare will be excluded on
the grounds that any between-group variation in homecare
costs is expected to be quantitatively unimportant.
Given the characteristic distribution of health costs
(truncated at zero and right skewed), the importance
of obtaining readily interpretable marginal effects, and
our interest in population-average effects, we will
model intervention effects on health service expendi-
ture and total costs using one-part GEEs with a log
link rather than transformed ordinary least squares or
two-part models [95]. Specification of the log link for
the GEE model permits natural interpretation of mar-
ginal effects on cost without retransformation [95].
Correlation structure, standard errors, and controls for
confounding variables will be as specified for the main
analysis.
Adjustment for differential timing
All costs will be inflated to current AUD for the year
of study completion. All costs and benefits will be
converted to present values for the year of study com-
pletion using an annual discount rate of 5% in the
base-case, and annual rates of 3% and 7% in sensitivity
analysis.
Incremental analysis
Results from the economic evaluation will be expressed
as: additional costs (savings) per x-ray referral and per
x-ray avoided to three months post-onset; additional
costs (savings) per any imaging referral and per any
imaging avoided to three months post-onset; additional
costs (savings) per point difference in RDQ at three
months post-onset; and additional costs (savings) per
QALY gained.
Uncertainty
Cost-effectiveness acceptability curves (CEACs) will be
derived from the joint density of incremental costs
(ΔC) and incremental effects (ΔE) for the intervention
as compared to existing practice. The joint density will
be obtained via non-parametric bootstrapping from the
distribution of observed cost/effect pairs for patient
participants. Separate CEACs will be derived for
upper/lower bound estimates of a pre-specified set of
uncertain parameters not estimated with sampling
error: development costs (none, full); unit cost for
practitioner participant time (AUD 0, average hourly
wage rate), unit cost for patient travel/waiting time to
attend treatment (AUD 0, average hourly wage rate),
and the discount rate (3%, 7%).
Publication policy
The investigators of the grant will be responsible for
ensuring the results of the trial are published within a
reasonable timeframe after conclusion of the trial. The
results from the trial will be published regardless of the
outcome. Reporting of this trial will adhere to the rele-
vant, and most up-to-date, CONSORT (Consolidated
Standards of Reporting Trials) statements at the time of
submission [79,96-99].
Ethical review
Ethical approval for this trial was obtained from the
Monash University Human Research Ethics Committee
(CF07/1060; CF09/1956). The investigators will ensure
the trial is conducted in compliance with this protocol
and the Australian National Statement on Ethical Con-
duct in Human Research [52].
Additional material
Additional file 1: ALIGN intervention content. This file includes an
outline of the symposium day, including a brief description of the
content in each session.
Additional file 2: ALIGN outcome definitions. This file provides
outcome definitions, including details of the measurement instruments
used.
Additional file 3: ALIGN data collection instruments. This file includes
practitioner and patient data collection instruments including the
practitioner vignettes, details of the measurement instruments for the
behavioural constructs, practitioner checklist (for physiotherapists), patient
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Page 14 of 17checklist, questionnaire for patients, fear-avoidance beliefs questionnaire
modifications, and data to be extracted from clinical file audit.
Additional file 4: ALIGN sample size calculations. This file includes
details of the assumptions and calculations in estimating the likely width
of the 95% CI for the risk difference and the log odds ratio, for the
primary practitioner outcome, x-ray referral.
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